Sydney A. Gilman - 28 Jul 2021 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
VP, Regulatory Affairs
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
28 Jul 2021
Net transactions value
$0
Form type
4
Filing time
29 Jul 2021, 21:18:27 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 0 28 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAC Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 28 Jul 2021 Common Shares 25,000 $5.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in sixteen nearly equal quarterly installments over four years.